How Elizabeth Holmes Deceived the Global Media: The Theranos Case
The Illusion of Innovation
In 2014, Elizabeth Holmes was the new face of the tech world. Her company, Theranos, promised a medical revolution: conducting blood tests using only a few drops of blood. At a time when Silicon Valley was captivated by the success of giants like Tesla, Airbnb, and Twitter, the Theranos concept fit perfectly into the prevailing narrative of innovation. Leading media outlets, including WIRED, Fortune, and The New Yorker, competed to profile Holmes, often labelling her the "next Steve Jobs."
However, as it later emerged, the entire operation was a carefully calculated fraud. The innovative blood-testing technology simply did not exist. When journalist John Carreyrou published his first exposé in 2015, it was revealed that Theranos laboratories were non-functional and that the results the company claimed to produce were falsified.
Why Did Journalists Believe It?
Today, with the Theranos saga closed and Holmes serving her sentence, many media outlets are attempting to analyse the mistakes made. At the time, journalists were actively seeking stories about female founders driving innovation in a male-dominated field. Holmes, with her signature black turtleneck and persuasive speaking style, perfectly embodied the role of the "genius outsider."
As former editors recall, the influential figures on the Theranos board, including former US high-ranking officials, created an illusion of credibility. Yet, there were red flags: the company failed to publish peer-reviewed scientific data, and Holmes herself refused to allow journalists to observe the actual analysis process. They frequently cited "security protocols" to ignore probing questions.
A Systemic Problem
Experts note that the Theranos case is not merely the fraud of one individual, but a reflection of Silicon Valley culture. The investment world often encourages "overconfidence," which can blur the line between reality and delusion. Investors frequently back individuals rather than finished products, providing significant opportunities for charismatic fraudsters.
Today, this story serves as an important lesson for the media. Critical thinking and the demand for scientific evidence are far more important than a beautifully packaged story about a successful founder. The Theranos case demonstrated that dangerous fraud can hide behind the banner of technological progress—a reality that is particularly critical and hazardous within the medical field.